Literature DB >> 34671129

Identifying causality, genetic correlation, priority and pathways of large-scale complex exposures of breast and ovarian cancers.

Shucheng Si1,2,3, Jiqing Li1,2,3, Marlvin Anemey Tewara4, Hongkai Li1,2,3, Xinhui Liu1,2,3, Yunxia Li1, Xiaolu Chen1, Congcong Liu1, Tonghui Yuan1, Wenchao Li1, Bojie Wang1, Fuzhong Xue5,6,7.   

Abstract

BACKGROUND: Genetic correlations, causalities and pathways between large-scale complex exposures and ovarian and breast cancers need systematic exploration.
METHODS: Mendelian randomisation (MR) and genetic correlation (GC) were used to identify causal biomarkers from 95 cancer-related exposures for risk of breast cancer [BC: oestrogen receptor-positive (ER + BC) and oestrogen receptor-negative (ER - BC) subtypes] and ovarian cancer [OC: high-grade serous (HGSOC), low-grade serous, invasive mucinous (IMOC), endometrioid (EOC) and clear cell (CCOC) subtypes].
RESULTS: Of 31 identified robust risk factors, 16 were new causal biomarkers for BC and OC. Body mass index (BMI), body fat mass (BFM), comparative body size at age 10 (CBS-10), waist circumference (WC) and education attainment were shared risk factors for overall BC and OC. Childhood obesity, BMI, CBS-10, WC, schizophrenia and age at menopause were significantly associated with ER + BC and ER - BC. Omega-6:omega-3 fatty acids, body fat-free mass and basal metabolic rate were positively associated with CCOC and EOC; BFM, linoleic acid, omega-6 fatty acids, CBS-10 and birth weight were significantly associated with IMOC; and body fat percentage, BFM and adiponectin were significantly associated with HGSOC. Both GC and MR identified 13 shared factors. Factors were stratified into five priority levels, and visual causal networks were constructed for future interventions.
CONCLUSIONS: With analysis of large-scale exposures for breast and ovarian cancers, causalities, genetic correlations, shared or specific factors, risk factor priority and causal pathways and networks were identified.
© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh:

Year:  2021        PMID: 34671129      PMCID: PMC8608803          DOI: 10.1038/s41416-021-01576-7

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   9.075


  69 in total

1.  [Studies on positive brain scintigrams associated with cerebrovascular accidents (author's transl)].

Authors:  Y Sugitani
Journal:  Nihon Naika Gakkai Zasshi       Date:  1973-08

2.  Alcohol consumption and risk of breast and ovarian cancer: A Mendelian randomization study.

Authors:  Jingjing Zhu; Xia Jiang; Zheng Niu
Journal:  Cancer Genet       Date:  2020-06-12

3.  Causal Pathways from Body Components and Regional Fat to Extensive Metabolic Phenotypes: A Mendelian Randomization Study.

Authors:  Shucheng Si; Marlvin Anemey Tewara; Yunxia Li; Wenchao Li; Xiaolu Chen; Tonghui Yuan; Congcong Liu; Jiqing Li; Bojie Wang; Hongkai Li; Lei Hou; Qing Wang; Fuzhong Xue
Journal:  Obesity (Silver Spring)       Date:  2020-08       Impact factor: 5.002

4.  Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.

Authors:  Farhad Islami; Ann Goding Sauer; Kimberly D Miller; Rebecca L Siegel; Stacey A Fedewa; Eric J Jacobs; Marjorie L McCullough; Alpa V Patel; Jiemin Ma; Isabelle Soerjomataram; W Dana Flanders; Otis W Brawley; Susan M Gapstur; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2017-11-21       Impact factor: 508.702

5.  How many cancer cases and deaths are potentially preventable? Estimates for Australia in 2013.

Authors:  Louise F Wilson; Annika Antonsson; Adele C Green; Susan J Jordan; Bradley J Kendall; Christina M Nagle; Rachel E Neale; Catherine M Olsen; Penelope M Webb; David C Whiteman
Journal:  Int J Cancer       Date:  2017-10-26       Impact factor: 7.396

6.  The fraction of cancer attributable to modifiable risk factors in England, Wales, Scotland, Northern Ireland, and the United Kingdom in 2015.

Authors:  Katrina F Brown; Harriet Rumgay; Casey Dunlop; Margaret Ryan; Frances Quartly; Alison Cox; Andrew Deas; Lucy Elliss-Brookes; Anna Gavin; Luke Hounsome; Dyfed Huws; Nick Ormiston-Smith; Jon Shelton; Ceri White; D Max Parkin
Journal:  Br J Cancer       Date:  2018-03-23       Impact factor: 7.640

7.  Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis.

Authors:  James Yarmolinsky; Caroline L Relton; Artitaya Lophatananon; Kenneth Muir; Usha Menon; Aleksandra Gentry-Maharaj; Axel Walther; Jie Zheng; Peter Fasching; Wei Zheng; Woo Yin Ling; Sue K Park; Byoung-Gie Kim; Ji-Yeob Choi; Boyoung Park; George Davey Smith; Richard M Martin; Sarah J Lewis
Journal:  PLoS Med       Date:  2019-08-07       Impact factor: 11.069

8.  The genetic interplay between body mass index, breast size and breast cancer risk: a Mendelian randomization analysis.

Authors:  Brandon Nick Sern Ooi; Huiwen Loh; Peh Joo Ho; Roger L Milne; Graham Giles; Chi Gao; Peter Kraft; Esther M John; Anthony Swerdlow; Hermann Brenner; Anna H Wu; Christopher Haiman; D Gareth Evans; Wei Zheng; Peter A Fasching; Jose Esteban Castelao; Ava Kwong; Xia Shen; Kamila Czene; Per Hall; Alison Dunning; Douglas Easton; Mikael Hartman; Jingmei Li
Journal:  Int J Epidemiol       Date:  2019-06-01       Impact factor: 7.196

9.  A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance.

Authors:  Alisa K Manning; Marie-France Hivert; Robert A Scott; Jonna L Grimsby; Nabila Bouatia-Naji; Han Chen; Denis Rybin; Ching-Ti Liu; Lawrence F Bielak; Inga Prokopenko; Najaf Amin; Daniel Barnes; Gemma Cadby; Jouke-Jan Hottenga; Erik Ingelsson; Anne U Jackson; Toby Johnson; Stavroula Kanoni; Claes Ladenvall; Vasiliki Lagou; Jari Lahti; Cecile Lecoeur; Yongmei Liu; Maria Teresa Martinez-Larrad; May E Montasser; Pau Navarro; John R B Perry; Laura J Rasmussen-Torvik; Perttu Salo; Naveed Sattar; Dmitry Shungin; Rona J Strawbridge; Toshiko Tanaka; Cornelia M van Duijn; Ping An; Mariza de Andrade; Jeanette S Andrews; Thor Aspelund; Mustafa Atalay; Yurii Aulchenko; Beverley Balkau; Stefania Bandinelli; Jacques S Beckmann; John P Beilby; Claire Bellis; Richard N Bergman; John Blangero; Mladen Boban; Michael Boehnke; Eric Boerwinkle; Lori L Bonnycastle; Dorret I Boomsma; Ingrid B Borecki; Yvonne Böttcher; Claude Bouchard; Eric Brunner; Danijela Budimir; Harry Campbell; Olga Carlson; Peter S Chines; Robert Clarke; Francis S Collins; Arturo Corbatón-Anchuelo; David Couper; Ulf de Faire; George V Dedoussis; Panos Deloukas; Maria Dimitriou; Josephine M Egan; Gudny Eiriksdottir; Michael R Erdos; Johan G Eriksson; Elodie Eury; Luigi Ferrucci; Ian Ford; Nita G Forouhi; Caroline S Fox; Maria Grazia Franzosi; Paul W Franks; Timothy M Frayling; Philippe Froguel; Pilar Galan; Eco de Geus; Bruna Gigante; Nicole L Glazer; Anuj Goel; Leif Groop; Vilmundur Gudnason; Göran Hallmans; Anders Hamsten; Ola Hansson; Tamara B Harris; Caroline Hayward; Simon Heath; Serge Hercberg; Andrew A Hicks; Aroon Hingorani; Albert Hofman; Jennie Hui; Joseph Hung; Marjo-Riitta Jarvelin; Min A Jhun; Paul C D Johnson; J Wouter Jukema; Antti Jula; W H Kao; Jaakko Kaprio; Sharon L R Kardia; Sirkka Keinanen-Kiukaanniemi; Mika Kivimaki; Ivana Kolcic; Peter Kovacs; Meena Kumari; Johanna Kuusisto; Kirsten Ohm Kyvik; Markku Laakso; Timo Lakka; Lars Lannfelt; G Mark Lathrop; Lenore J Launer; Karin Leander; Guo Li; Lars Lind; Jaana Lindstrom; Stéphane Lobbens; Ruth J F Loos; Jian'an Luan; Valeriya Lyssenko; Reedik Mägi; Patrik K E Magnusson; Michael Marmot; Pierre Meneton; Karen L Mohlke; Vincent Mooser; Mario A Morken; Iva Miljkovic; Narisu Narisu; Jeff O'Connell; Ken K Ong; Ben A Oostra; Lyle J Palmer; Aarno Palotie; James S Pankow; John F Peden; Nancy L Pedersen; Marina Pehlic; Leena Peltonen; Brenda Penninx; Marijana Pericic; Markus Perola; Louis Perusse; Patricia A Peyser; Ozren Polasek; Peter P Pramstaller; Michael A Province; Katri Räikkönen; Rainer Rauramaa; Emil Rehnberg; Ken Rice; Jerome I Rotter; Igor Rudan; Aimo Ruokonen; Timo Saaristo; Maria Sabater-Lleal; Veikko Salomaa; David B Savage; Richa Saxena; Peter Schwarz; Udo Seedorf; Bengt Sennblad; Manuel Serrano-Rios; Alan R Shuldiner; Eric J G Sijbrands; David S Siscovick; Johannes H Smit; Kerrin S Small; Nicholas L Smith; Albert Vernon Smith; Alena Stančáková; Kathleen Stirrups; Michael Stumvoll; Yan V Sun; Amy J Swift; Anke Tönjes; Jaakko Tuomilehto; Stella Trompet; Andre G Uitterlinden; Matti Uusitupa; Max Vikström; Veronique Vitart; Marie-Claude Vohl; Benjamin F Voight; Peter Vollenweider; Gerard Waeber; Dawn M Waterworth; Hugh Watkins; Eleanor Wheeler; Elisabeth Widen; Sarah H Wild; Sara M Willems; Gonneke Willemsen; James F Wilson; Jacqueline C M Witteman; Alan F Wright; Hanieh Yaghootkar; Diana Zelenika; Tatijana Zemunik; Lina Zgaga; Nicholas J Wareham; Mark I McCarthy; Ines Barroso; Richard M Watanabe; Jose C Florez; Josée Dupuis; James B Meigs; Claudia Langenberg
Journal:  Nat Genet       Date:  2012-05-13       Impact factor: 38.330

10.  Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study.

Authors:  Shiu Lun Au Yeung; Catherine Mary Schooling
Journal:  BMJ Open Diabetes Res Care       Date:  2019-12-29
View more
  1 in total

Review 1.  Targeting lipid metabolism in the treatment of ovarian cancer.

Authors:  Saliha Chaudhry; Stefani N Thomas; Glenn E Simmons
Journal:  Oncotarget       Date:  2022-05-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.